Quant Small Cap Fund, a key product of Quant Mutual Fund, is primarily focused on generating capital growth by placing investments in a selection of small-cap firms. Their portfolio saw the incorporation of more shares from Gland Pharma, Ethos, and Aster DM Healthcare, marking a strategic shift in its holding patterns.
Gland Pharma, a noted firm, saw approximately 7.55 lakh of its shares assimilated into the fund’s constantly adapting portfolio. This capital movement, aimed at boosting future capital growth, clearly indicates the fund’s positive outlook towards this pharma industry player.
The strategy continued with Ethos and Aster DM Healthcare too, with an infusion of 16,000 and 2.51 lakh shares respectively. This addition in the given timeframe marked a consistent trend in Quant Small Cap Fund’s approach towards potential growth avenues within the scope of its small-cap investment philosophy.
On the other end of the spectrum, the fund lessened its stake in eight different stocks, demonstrating a market-agnostic approach to optimizing returns. Aditya Birla Fashion and Retail, Anupam Rasayan India, Bikaji Foods International, HP Adhesives, India Shelter Fin Corp, Jana Small Finance Bank, One Source Speciality Pharma, and Taj GVK Hotels & Resorts figured on this list.
It’s interesting to note that Quant Small Cap Fund decided to entirely exit Siemens Energy India and PG Electroplast. It sold roughly 7.20 lakh and 14.06 lakh shares respectively in the month of August, signifying a complete divestiture from these particular entities.
However, around 85 stocks maintained their position in the fund’s portfolio. This list of unchanged holdings includes reputed names like Adani Enterprises, Adani Power, Anthem Biosciences, Balrampur Chini Mills, Castrol India, Jio Financial Services, Jubilant Pharmova, Juniper Hotels, Laxmi Dental, LIC, NCC, ONGC, and RIL.
Interestingly, the Quant Small Cap Fund didn’t introduce any new stock into its portfolio within the discussed time frame. The sturdy composition of the portfolio, in lieu of adding new stocks, highlights the fund’s strategy of focusing on maximising returns from existing investments.
The total tally of stocks in the portfolio physics differed in consecutive months. While in August, the portfolio housed 96 different stocks, it had counted 98 in July. Such slight changes are a testament to the dynamic nature of funds like Quant Small Cap Fund.
As of August 29, 2025, the fund had an Asset Under Management (AUM) totaling Rs. 28,758 crore. This sizeable figure further emphasises the Fund’s impressive scale and its role within the broader financial ecosystem.
In conclusion, the Quant Small Cap Fund’s continuous strategic investment and divestiture, whether it’s increasing stakes in selected firms or reducing in others, underline its commitment to generating long-term growth.
Its tactics reveal a meticulously devised plan that capitalises on potential higher return small-cap companies, while at the same time navigating the inherent risks associated with them.
This intricate interplay, shown in their decisions to maintain, increase, decrease, or fully withdraw their stakes in various firms, shows the fund’s vigilant adaption to market fluctuations and its strategic response to garner maximum returns for its investors.
Hence, the operations of Quant Small Cap Fund within this specified timeframe follow a pattern reflective of their broader investment objectives: to optimise capital appreciation and advancement by relying mainly on the potential of small-cap companies.
The post Quant Small Cap Fund Diversifies Portfolio With Gland Pharma, Ethos, Aster DM appeared first on Real News Now.
About Author
